ENDO 2016: Women’s Health – Part 2

In the second half of this update on women’s health from ENDO 2016, Arun Karlamangla, University of California, Los Angeles presents his group’s work on a new assay to measure anti-Mullerian hormone as a potential means to predict bone density loss during trans-menopause. We also look at a possible link between asthma and polycystic ovary syndrome, discussed by Anju Joham, Monash University, Melbourne, Australia.